Reduced NK activity in pulmonary tuberculosis patients with/without HIV infection: identifying the defective stage and studying the effect of interleukins on NK activity

被引:27
作者
Nirmala, R
Narayanan, PR
Mathew, R
Maran, M
Deivanayagam, CN
机构
[1] TB Res Ctr, Chennai 600031, India
[2] State Govt Hosp Thorac Med, Chennai, India
关键词
D O I
10.1054/tube.2001.0309
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Setting: A study was undertaken to understand the non-major histocompatibility restricted cytotoxicity in order to delineate the role of natural killer (NK) cells towards the development of host immunity to tuberculosis. Objective: (a) Enumeration of NK cell numbers and activity in normal individuals (35), pulmonary tuberculosis patients (32), HIV-infected TB patients (20) and patient contacts (10), (b) effect of treatment on NK status, (c) enumeration of effector-target conjugates and (d) effect of in vitro cytokine stimulation on NK activity. Design: NK cells were enumerated by flowcytometry. NK activity was assessed by chromium release assay before and after treatment for tuberculosis and after stimulation with IL-2/IL-12. Novel flow cytometric method was standardized to enumerate effector-target conjugates. Results: No changes were seen between different groups as far as number of NK cells and relative proportions of different conjugate types were concerned, but there was a decrease in NK activity in TB patients which increased after treatment. Augmentation of NK activity was observed after cytokine stimulation. Conclusion: Lowered NK activity during tuberculosis infection is probably the 'effect' and not the 'cause' for the disease as demonstrated by the follow-up study. Similar number of conjugates in both groups indicates no defect in the recognition/binding step but probably at subsequent steps of the cytotoxic process, Augmentation of NK activity with cytokines implicates them as potential adjuncts to tuberculosis chemotherapy. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:343 / 352
页数:10
相关论文
共 45 条
[1]  
ADAMBEKOV DA, 1995, ZH MIKROBIOL EPIDEMI, V1, P18
[2]  
BARNES PF, 1990, J IMMUNOL, V145, P149
[3]  
BENDALL LJ, 1995, LEUKEMIA, V9, P677
[4]  
BONAVIDA B, 1986, J IMMUNOL, V137, P1157
[5]   ROLE OF NATURAL-KILLER CYTOTOXIC FACTORS IN THE MECHANISM OF TARGET-CELL KILLING BY NATURAL-KILLER-CELLS [J].
BONAVIDA, B ;
WRIGHT, SC .
JOURNAL OF CLINICAL IMMUNOLOGY, 1986, 6 (01) :1-8
[6]  
CHONG ASF, 1989, J IMMUNOL, V142, P2133
[7]   INTERFERON-GAMMA-TREATED MURINE MACROPHAGES INHIBIT GROWTH OF TUBERCLE-BACILLI VIA THE GENERATION OF REACTIVE NITROGEN INTERMEDIATES [J].
DENIS, M .
CELLULAR IMMUNOLOGY, 1991, 132 (01) :150-157
[8]   INTERLEUKIN-12 (IL-12) AUGMENTS CYTOLYTIC ACTIVITY OF NATURAL-KILLER-CELLS TOWARD MYCOBACTERIUM TUBERCULOSIS-INFECTED HUMAN MONOCYTES [J].
DENIS, M .
CELLULAR IMMUNOLOGY, 1994, 156 (02) :529-536
[9]  
DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213
[10]   Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Myco-avium [J].
Esin, S ;
Batoni, G ;
Kallenius, G ;
Gaines, H ;
Campa, M ;
Svenson, SB ;
Andersson, R ;
Wigzell, H .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (03) :419-425